Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Death Receptor-Mediated Apoptosis and Therapy Strategies in Ovarian Cancer

NCT00711932 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT00711932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00711932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Death Receptor-Mediated Apoptosis and Therapy Strategies in Ovarian Cancer
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
January 31, 2013
Enrollment
478 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer